<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">68447</article-id><article-id pub-id-type="doi">10.7554/eLife.68447</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Acid-base transporters and pH dynamics in human breast carcinomas predict proliferative activity, metastasis, and survival</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-231818"><name><surname>Toft</surname><given-names>Nicolai J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231819"><name><surname>Axelsen</surname><given-names>Trine V</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231820"><name><surname>Pedersen</surname><given-names>Helene L</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231821"><name><surname>Mele</surname><given-names>Marco</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8156-7804</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231822"><name><surname>Burton</surname><given-names>Mark</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231823"><name><surname>Balling</surname><given-names>Eva</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231824"><name><surname>Johansen</surname><given-names>Tonje</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231826"><name><surname>Thomassen</surname><given-names>Mads</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231825"><name><surname>Christiansen</surname><given-names>Peer M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-181974"><name><surname>Boedtkjer</surname><given-names>Ebbe</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5078-9279</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><institution content-type="dept">Department of Biomedicine</institution>, <institution>Aarhus University</institution>, <addr-line><named-content content-type="city">Aarhus C</named-content></addr-line>, <country>Denmark</country></aff><aff id="aff2"><institution content-type="dept">Department of Pathology</institution>, <institution>Regionshospitalet Randers</institution>, <addr-line><named-content content-type="city">Randers</named-content></addr-line>, <country>Denmark</country></aff><aff id="aff3"><institution content-type="dept">Department of Surgery</institution>, <institution>Regionshospitalet Randers</institution>, <addr-line><named-content content-type="city">Randers</named-content></addr-line>, <country>Denmark</country></aff><aff id="aff4"><institution content-type="dept">Department of Clinical Genetics</institution>, <institution>University of Southern Denmark</institution>, <addr-line><named-content content-type="city">Odense</named-content></addr-line>, <country>Denmark</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-156274"><name><surname>Liu</surname><given-names>Caigang</given-names></name><role>Reviewing editor</role><aff><institution>Shengjing Hospital of China Medical University</institution>, <country>China</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>eb@biomed.au.dk</email> (EB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>05</day><month>07</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e68447</elocation-id><history><date date-type="received"><day>16</day><month>03</month><year>2021</year></date><date date-type="accepted"><day>02</day><month>07</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Toft et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Toft et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-68447-v1.pdf"/><abstract><p>Breast cancer heterogeneity in histology and molecular subtype influences metabolic and proliferative activity and hence the acid load on cancer cells. We hypothesized that acid-base transporters and intracellular pH (pH<sub>i</sub>) dynamics contribute inter-individual variability in breast cancer aggressiveness and prognosis. We show that Na<sup>+</sup>,HCO<sub>3</sub><sup>-</sup>-cotransport and Na<sup>+</sup>/H<sup>+</sup>-exchange dominate cellular net acid extrusion in human breast carcinomas. Na<sup>+</sup>/H<sup>+</sup>-exchange elevates pH<sub>i</sub> preferentially in estrogen receptor-negative breast carcinomas, whereas Na<sup>+</sup>,HCO<sub>3</sub><sup>-</sup>-cotransport raises pH<sub>i</sub> more in invasive lobular than ductal breast carcinomas and in higher malignancy grade breast cancer. HER2-positive breast carcinomas have elevated protein expression of Na<sup>+</sup>/H<sup>+</sup>-exchanger NHE1/SLC9A1 and Na<sup>+</sup>,HCO<sub>3</sub><sup>-</sup>-cotransporter NBCn1/SLC4A7. Increased dependency on Na<sup>+</sup>,HCO<sub>3</sub><sup>-</sup>-cotransport associates with severe breast cancer: enlarged CO<sub>2</sub>/HCO<sub>3</sub><sup>-</sup>-dependent rises in pH<sub>i</sub> predict accelerated cell proliferation; whereas enhanced CO<sub>2</sub>/HCO<sub>3</sub><sup>-</sup>-dependent net acid extrusion, elevated NBCn1 protein expression, and reduced NHE1 protein expression predict lymph node metastasis. Accordingly, we observe reduced survival for patients suffering from Luminal A or Basal-like/triple-negative breast cancer with high <italic>SLC4A7</italic> and/or low <italic>SLC9A1</italic> mRNA expression. We conclude that the molecular mechanisms of acid-base regulation depend on clinicopathological characteristics of breast cancer patients. NBCn1 expression and dependency on Na<sup>+</sup>,HCO<sub>3</sub><sup>-</sup>-cotransport for pH<sub>i</sub> regulation, measured in biopsies of human primary breast carcinomas, independently predict proliferative activity, lymph node metastasis, and patient survival.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008392</institution-id><institution>Sundhed og Sygdom, Det Frie Forskningsråd</institution></institution-wrap></funding-source><award-id>7025-00050B</award-id><principal-award-recipient><name><surname>Boedtkjer</surname><given-names>Ebbe</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009708</institution-id><institution>Novo Nordisk Fonden</institution></institution-wrap></funding-source><award-id>NNF18OC0053037</award-id><principal-award-recipient><name><surname>Boedtkjer</surname><given-names>Ebbe</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Danish Cancer Society</institution></institution-wrap></funding-source><award-id>R136-A8670</award-id><principal-award-recipient><name><surname>Toft</surname><given-names>Nicolai J</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Ebbe Boedtkjer, is an inventor on patents covering NBCn1 as target for cancer therapy (EP 3271402)..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: All participants gave written informed consent. The Mid-Jutland regional division of the Danish Committee on Health Research Ethics (M-20100288) and the Danish Data Protection Agency (1-16-02-191-16) approved the procedures for tissue sampling and data handling, respectively.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>- In order to comply with the ethical approval, we share the human data presented in Figure 1-8 and corresponding Figure Supplements (data on acid-base transport activity, intracellular pH, and protein expression of transporters linked to clinicopathological information) in de-identified form. Following consultation with the legal team at the Regional Committee on Health Research Ethics, we have generated dataset files where restricted information is grouped in intervals each consisting of no less than five individuals. To provide the reader with the best possible data insight, we also show Figure Supplements with more detailed and advanced plots of the data and include the corresponding de-identified dataset.- The meta analyses presented in Figure 9, 10, and corresponding figure supplements (data on RNA expression linked to patient survival) are based on data that have previously been published by other investigators (references 28-34), as detailed in the manuscript and the dataset list.</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>van de Vijver  MJ</collab><collab>He YD</collab><collab>van't Veer LJ</collab><collab>Dai H</collab><collab>Hart AAM</collab><collab>Voskuil DW</collab><collab>Schreiber GJ</collab><collab>Peterse JL</collab><collab>Roberts C</collab><collab>Marton MJ</collab><collab>Parrish M</collab><collab>Atsma D</collab><collab>Witteveen A</collab><collab>Glas A</collab><collab>Delahaye L</collab><collab>van der Velde T</collab><collab>Bartelink H</collab><collab>Rodenhuis S</collab><collab>Rutgers ET</collab><collab>Friend SH</collab><collab>Bernards R</collab></person-group><year iso-8601-date="2002">2002</year><source>A gene-expression signature as a predictor of survival in breast cancer</source><ext-link ext-link-type="uri" xlink:href="http://bioconductor.org/packages/release/data/experiment/html/cancerdata.html">http://bioconductor.org/packages/release/data/experiment/html/cancerdata.html</ext-link><comment>Budczies J, Kosztyla D (2020). cancerdata: Development and validation of diagnostic tests from high-dimensional molecular data: Datasets. R package version 1.28.0.; data(Vijver)</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Calza S</collab><collab>Hall P</collab><collab>Auer G</collab><collab>Bjöhle J</collab><collab>Klaar S</collab><collab>Kronenwett U</collab><collab>Liu ET</collab><collab>Miller L</collab><collab>Ploner A</collab><collab>Smeds J</collab><collab>Bergh J</collab><collab>Pawitan Y</collab></person-group><year iso-8601-date="2006">2006</year><source>Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients</source><ext-link ext-link-type="uri" xlink:href="https://www.meb.ki.se/sites/yudpaw/wp-content/uploads/sites/5/papers/Intrinsic_Signature.zip">https://www.meb.ki.se/sites/yudpaw/wp-content/uploads/sites/5/papers/Intrinsic_Signature.zip</ext-link><comment>Yudi Pawitan uploads; Intrinsic_signature</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Hu Z</collab><collab>Fan C</collab><collab>Oh DS</collab><collab>Marron JS</collab><collab>He X</collab><collab>Qaqish BF</collab><collab>Livasy C</collab><collab>Carey LA</collab><collab>Reynolds E</collab><collab>Dressler L</collab><collab>Nobel A</collab><collab>Parker J</collab><collab>Ewend MG</collab><collab>Sawyer LR</collab><collab>Wu J</collab><collab>Liu Y</collab><collab>Nanda R</collab><collab>Tretiakova M</collab><collab>Orrico AR</collab><collab>Dreher D</collab><collab>Palazzo JP</collab><collab>Perreard L</collab><collab>Nelson E</collab><collab>Mone M</collab><collab>Hansen H</collab><collab>Mullins M</collab><collab>Quackenbush JF</collab><collab>Ellis MJ</collab><collab>Olopade OI</collab><collab>Bernard PS</collab><collab>Perou CM</collab></person-group><year iso-8601-date="2006">2006</year><source>The molecular portraits of breast tumors are conserved across microarray platforms</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE1992">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE1992</ext-link><comment>NCBI Gene Expression Omnibus, GSE1992</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Wang Y</collab><collab>Klijn JGM</collab><collab>Zhang Y</collab><collab>Sieuwerts AM</collab><collab>Look MP</collab><collab>Yang F</collab><collab>Talantov D</collab><collab>Timmermans M</collab><collab>van Gelder MEM</collab><collab>Yu J</collab><collab>Jatkoe T</collab><collab>Berns EMJJ</collab><collab>Atkins D</collab><collab>Foekens JA</collab></person-group><year iso-8601-date="2005">2005</year><source>Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE2034">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE2034</ext-link><comment>NCBI Gene Expression Omnibus, GSE2034</comment></element-citation><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Schmidt M</collab><collab>Böhm D</collab><collab>von Törne C</collab><collab>Steiner E</collab><collab>Puhl A</collab><collab>Pilch H</collab><collab>Lehr H-A</collab><collab>Hengstler JG</collab><collab>Kölbl H</collab><collab>Gehrmann M</collab></person-group><year iso-8601-date="2008">2008</year><source>The humoral immune system has a key prognostic impact in node-negative breast cancer</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE11121">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE11121</ext-link><comment>NCBI Gene Expression Omnibus, GSE11121</comment></element-citation><element-citation id="dataset6" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Bild AH</collab><collab>Yao G</collab><collab>Chang JT</collab><collab>Wang Q</collab><collab>Potti A</collab><collab>Chasse D</collab><collab>Joshi M-B</collab><collab>Harpole D</collab><collab>Lancaster JM</collab><collab>Berchuck A</collab><collab>Olson Jr JA</collab><collab>Marks JR</collab><collab>Dressman HK</collab><collab>West M</collab><collab>Nevins JR</collab></person-group><year iso-8601-date="2006">2006</year><source>Oncogenic pathway signatures in human cancers as a guide to targeted therapies</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE3143">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE3143</ext-link><comment>NCBI Gene Expression Omnibus, GSE3143</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-68447-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>